United States · FDA National Drug Code directory
Naftin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54766-772_43150f38-df38-5e12-e063-6294a90a1128
- Product NDC
- 54766-772
- Form
- GEL
- Composition / generic term
- Naftifine Hydrochloride
- Labeler
- Sebela Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180301 / 20261031
Source-listed ingredients
- NAFTIFINE HYDROCHLORIDE — 2 g/100g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (54766-772-45) / 45 g in 1 TUBE · 54766-772-45
- 1 TUBE in 1 CARTON (54766-772-60) / 60 g in 1 TUBE · 54766-772-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →